Free Trial

InMed Pharmaceuticals (INM) SEC Filings & 10K Form

InMed Pharmaceuticals logo
$2.98 +0.03 (+1.02%)
As of 04/24/2025 04:00 PM Eastern

Recent InMed Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/02/2025
3:13 PM
AdvisorShares Trust (Filed by)
InMed Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/14/2025
1:56 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2025
8:38 AM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2025
4:30 PM
InMed Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/03/2025
10:20 AM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/03/2025
7:49 AM
HULL ANDREW (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
9:18 AM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2025
9:54 AM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2025
10:46 AM
InMed Pharmaceuticals (Filer)
Form 424B3
01/01/2025
11:15 PM
InMed Pharmaceuticals (Filer)
Form EFFECT
12/30/2024
11:16 AM
InMed Pharmaceuticals (Filer)
Form S-1/A
12/23/2024
4:16 PM
InMed Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
12/23/2024
8:25 AM
InMed Pharmaceuticals (Issuer)
Lemerond Nicole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
8:26 AM
InMed Pharmaceuticals (Issuer)
Jagpal Netta (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
8:28 AM
InMed Pharmaceuticals (Issuer)
Johnson Shane Aaron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
8:17 AM
HULL ANDREW (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
8:18 AM
Baldasare Bryan T (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
8:20 AM
ADAMS ERIC A (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
8:21 AM
HSU ERIC C (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
8:22 AM
Grove Janet P (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2024
8:24 AM
InMed Pharmaceuticals (Issuer)
WOUDENBERG MICHAEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
5:18 AM
InMed Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/19/2024
10:55 AM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
7:05 AM
InMed Pharmaceuticals (Subject)
YA II PN, Ltd. (Filed by)
Form SCHEDULE 13G
11/12/2024
12:44 PM
AdvisorShares Trust (Filed by)
InMed Pharmaceuticals (Subject)
Form SC 13G
11/05/2024
8:08 AM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2024
3:50 PM
InMed Pharmaceuticals (Filer)
Form DEF 14A
10/28/2024
3:00 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2024
2:25 PM
InMed Pharmaceuticals (Filer)
Form DEFA14A
10/24/2024
2:57 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2024
11:28 AM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
5:30 AM
InMed Pharmaceuticals (Filer)
Form 424B3
09/30/2024
12:37 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2024
3:10 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2024
1:04 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2024
1:00 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2024
2:08 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2024
7:32 PM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2024
11:48 AM
InMed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2024
3:26 PM
HSU ERIC C (Reporting)
InMed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:INM) was last updated on 4/25/2025 by MarketBeat.com Staff
From Our Partners